nodes	percent_of_prediction	percent_of_DWPC	metapath
Acamprosate—GRIN2A—melanoma	0.706	1	CbGaD
Acamprosate—Haemorrhage—Temozolomide—melanoma	0.000334	0.00258	CcSEcCtD
Acamprosate—Hepatitis—Temozolomide—melanoma	0.000334	0.00258	CcSEcCtD
Acamprosate—Asthenia—Vemurafenib—melanoma	0.000333	0.00257	CcSEcCtD
Acamprosate—Visual impairment—Carmustine—melanoma	0.000333	0.00257	CcSEcCtD
Acamprosate—Hallucination—Temozolomide—melanoma	0.000333	0.00256	CcSEcCtD
Acamprosate—Hypoaesthesia—Temozolomide—melanoma	0.000333	0.00256	CcSEcCtD
Acamprosate—Pharyngitis—Temozolomide—melanoma	0.000332	0.00256	CcSEcCtD
Acamprosate—Chills—Dactinomycin—melanoma	0.000332	0.00256	CcSEcCtD
Acamprosate—Oedema peripheral—Temozolomide—melanoma	0.000329	0.00254	CcSEcCtD
Acamprosate—Cardiac failure—Docetaxel—melanoma	0.000329	0.00254	CcSEcCtD
Acamprosate—Pruritus—Vemurafenib—melanoma	0.000329	0.00253	CcSEcCtD
Acamprosate—Alopecia—Dactinomycin—melanoma	0.000327	0.00252	CcSEcCtD
Acamprosate—Hyponatraemia—Docetaxel—melanoma	0.000323	0.00249	CcSEcCtD
Acamprosate—Visual impairment—Temozolomide—melanoma	0.000322	0.00248	CcSEcCtD
Acamprosate—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000321	0.00248	CcSEcCtD
Acamprosate—Ill-defined disorder—Bleomycin—melanoma	0.00032	0.00247	CcSEcCtD
Acamprosate—Anaemia—Bleomycin—melanoma	0.000319	0.00246	CcSEcCtD
Acamprosate—Diarrhoea—Vemurafenib—melanoma	0.000318	0.00245	CcSEcCtD
Acamprosate—Migraine—Docetaxel—melanoma	0.000316	0.00244	CcSEcCtD
Acamprosate—Tinnitus—Temozolomide—melanoma	0.000312	0.0024	CcSEcCtD
Acamprosate—Malaise—Bleomycin—melanoma	0.000311	0.0024	CcSEcCtD
Acamprosate—Leukopenia—Bleomycin—melanoma	0.000309	0.00238	CcSEcCtD
Acamprosate—Dizziness—Vemurafenib—melanoma	0.000307	0.00237	CcSEcCtD
Acamprosate—Alopecia—Carmustine—melanoma	0.000306	0.00236	CcSEcCtD
Acamprosate—Mental disorder—Carmustine—melanoma	0.000303	0.00234	CcSEcCtD
Acamprosate—Immune system disorder—Temozolomide—melanoma	0.000302	0.00233	CcSEcCtD
Acamprosate—Malnutrition—Carmustine—melanoma	0.000301	0.00232	CcSEcCtD
Acamprosate—Cough—Bleomycin—melanoma	0.000301	0.00232	CcSEcCtD
Acamprosate—Chills—Temozolomide—melanoma	0.0003	0.00231	CcSEcCtD
Acamprosate—Ill-defined disorder—Dactinomycin—melanoma	0.000299	0.0023	CcSEcCtD
Acamprosate—Anaemia—Dactinomycin—melanoma	0.000297	0.00229	CcSEcCtD
Acamprosate—Liver function test abnormal—Docetaxel—melanoma	0.000297	0.00229	CcSEcCtD
Acamprosate—Vomiting—Vemurafenib—melanoma	0.000296	0.00228	CcSEcCtD
Acamprosate—Alopecia—Temozolomide—melanoma	0.000295	0.00228	CcSEcCtD
Acamprosate—Dry skin—Docetaxel—melanoma	0.000295	0.00227	CcSEcCtD
Acamprosate—Chest pain—Bleomycin—melanoma	0.000294	0.00226	CcSEcCtD
Acamprosate—Myalgia—Bleomycin—melanoma	0.000294	0.00226	CcSEcCtD
Acamprosate—Orthostatic hypotension—Docetaxel—melanoma	0.000294	0.00226	CcSEcCtD
Acamprosate—Rash—Vemurafenib—melanoma	0.000293	0.00226	CcSEcCtD
Acamprosate—Mental disorder—Temozolomide—melanoma	0.000293	0.00226	CcSEcCtD
Acamprosate—Dermatitis—Vemurafenib—melanoma	0.000293	0.00226	CcSEcCtD
Acamprosate—Back pain—Carmustine—melanoma	0.000291	0.00224	CcSEcCtD
Acamprosate—Headache—Vemurafenib—melanoma	0.000291	0.00224	CcSEcCtD
Acamprosate—Malnutrition—Temozolomide—melanoma	0.000291	0.00224	CcSEcCtD
Acamprosate—Breast disorder—Docetaxel—melanoma	0.00029	0.00224	CcSEcCtD
Acamprosate—Discomfort—Bleomycin—melanoma	0.00029	0.00224	CcSEcCtD
Acamprosate—Malaise—Dactinomycin—melanoma	0.00029	0.00224	CcSEcCtD
Acamprosate—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000289	0.00223	CcSEcCtD
Acamprosate—Leukopenia—Dactinomycin—melanoma	0.000288	0.00222	CcSEcCtD
Acamprosate—Dysgeusia—Temozolomide—melanoma	0.000285	0.0022	CcSEcCtD
Acamprosate—Confusional state—Bleomycin—melanoma	0.000284	0.00219	CcSEcCtD
Acamprosate—Alanine aminotransferase increased—Docetaxel—melanoma	0.000283	0.00218	CcSEcCtD
Acamprosate—Tremor—Carmustine—melanoma	0.000282	0.00217	CcSEcCtD
Acamprosate—Anaphylactic shock—Bleomycin—melanoma	0.000282	0.00217	CcSEcCtD
Acamprosate—Back pain—Temozolomide—melanoma	0.000282	0.00217	CcSEcCtD
Acamprosate—Infection—Bleomycin—melanoma	0.00028	0.00216	CcSEcCtD
Acamprosate—Anaemia—Carmustine—melanoma	0.000278	0.00214	CcSEcCtD
Acamprosate—Dysphagia—Docetaxel—melanoma	0.000278	0.00214	CcSEcCtD
Acamprosate—Agitation—Carmustine—melanoma	0.000277	0.00213	CcSEcCtD
Acamprosate—Nausea—Vemurafenib—melanoma	0.000276	0.00213	CcSEcCtD
Acamprosate—Thrombocytopenia—Bleomycin—melanoma	0.000276	0.00212	CcSEcCtD
Acamprosate—Myalgia—Dactinomycin—melanoma	0.000274	0.00211	CcSEcCtD
Acamprosate—Tremor—Temozolomide—melanoma	0.000273	0.0021	CcSEcCtD
Acamprosate—Discomfort—Dactinomycin—melanoma	0.000271	0.00209	CcSEcCtD
Acamprosate—Angina pectoris—Docetaxel—melanoma	0.000271	0.00208	CcSEcCtD
Acamprosate—Ill-defined disorder—Temozolomide—melanoma	0.00027	0.00208	CcSEcCtD
Acamprosate—Leukopenia—Carmustine—melanoma	0.00027	0.00208	CcSEcCtD
Acamprosate—Anaemia—Temozolomide—melanoma	0.000269	0.00207	CcSEcCtD
Acamprosate—Anorexia—Bleomycin—melanoma	0.000268	0.00207	CcSEcCtD
Acamprosate—Agitation—Temozolomide—melanoma	0.000267	0.00206	CcSEcCtD
Acamprosate—Angioedema—Temozolomide—melanoma	0.000266	0.00205	CcSEcCtD
Acamprosate—Hypotension—Bleomycin—melanoma	0.000263	0.00203	CcSEcCtD
Acamprosate—Malaise—Temozolomide—melanoma	0.000262	0.00202	CcSEcCtD
Acamprosate—Vertigo—Temozolomide—melanoma	0.000262	0.00201	CcSEcCtD
Acamprosate—Convulsion—Carmustine—melanoma	0.000261	0.00201	CcSEcCtD
Acamprosate—Infection—Dactinomycin—melanoma	0.000261	0.00201	CcSEcCtD
Acamprosate—Leukopenia—Temozolomide—melanoma	0.000261	0.00201	CcSEcCtD
Acamprosate—Hypertension—Carmustine—melanoma	0.00026	0.002	CcSEcCtD
Acamprosate—Palpitations—Temozolomide—melanoma	0.000257	0.00198	CcSEcCtD
Acamprosate—Thrombocytopenia—Dactinomycin—melanoma	0.000257	0.00198	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Bleomycin—melanoma	0.000257	0.00198	CcSEcCtD
Acamprosate—Chest pain—Carmustine—melanoma	0.000256	0.00198	CcSEcCtD
Acamprosate—Myalgia—Carmustine—melanoma	0.000256	0.00198	CcSEcCtD
Acamprosate—Anxiety—Carmustine—melanoma	0.000256	0.00197	CcSEcCtD
Acamprosate—Cough—Temozolomide—melanoma	0.000254	0.00196	CcSEcCtD
Acamprosate—Paraesthesia—Bleomycin—melanoma	0.000253	0.00195	CcSEcCtD
Acamprosate—Weight increased—Docetaxel—melanoma	0.000253	0.00195	CcSEcCtD
Acamprosate—Convulsion—Temozolomide—melanoma	0.000252	0.00194	CcSEcCtD
Acamprosate—Weight decreased—Docetaxel—melanoma	0.000251	0.00194	CcSEcCtD
Acamprosate—Hypertension—Temozolomide—melanoma	0.000251	0.00194	CcSEcCtD
Acamprosate—Dyspnoea—Bleomycin—melanoma	0.000251	0.00193	CcSEcCtD
Acamprosate—Anorexia—Dactinomycin—melanoma	0.00025	0.00193	CcSEcCtD
Acamprosate—Pneumonia—Docetaxel—melanoma	0.000249	0.00192	CcSEcCtD
Acamprosate—Confusional state—Carmustine—melanoma	0.000248	0.00191	CcSEcCtD
Acamprosate—Arthralgia—Temozolomide—melanoma	0.000248	0.00191	CcSEcCtD
Acamprosate—Myalgia—Temozolomide—melanoma	0.000248	0.00191	CcSEcCtD
Acamprosate—Anxiety—Temozolomide—melanoma	0.000247	0.0019	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.000246	0.0019	CcSEcCtD
Acamprosate—Discomfort—Temozolomide—melanoma	0.000245	0.00189	CcSEcCtD
Acamprosate—Decreased appetite—Bleomycin—melanoma	0.000245	0.00189	CcSEcCtD
Acamprosate—Infection—Carmustine—melanoma	0.000244	0.00188	CcSEcCtD
Acamprosate—Acute coronary syndrome—Docetaxel—melanoma	0.000244	0.00188	CcSEcCtD
Acamprosate—Myocardial infarction—Docetaxel—melanoma	0.000243	0.00187	CcSEcCtD
Acamprosate—Dry mouth—Temozolomide—melanoma	0.000242	0.00187	CcSEcCtD
Acamprosate—Stomatitis—Docetaxel—melanoma	0.000241	0.00186	CcSEcCtD
Acamprosate—Pain—Bleomycin—melanoma	0.000241	0.00186	CcSEcCtD
Acamprosate—Thrombocytopenia—Carmustine—melanoma	0.000241	0.00185	CcSEcCtD
Acamprosate—Tachycardia—Carmustine—melanoma	0.00024	0.00185	CcSEcCtD
Acamprosate—Confusional state—Temozolomide—melanoma	0.00024	0.00185	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000239	0.00184	CcSEcCtD
Acamprosate—Anaphylactic shock—Temozolomide—melanoma	0.000238	0.00183	CcSEcCtD
Acamprosate—Infection—Temozolomide—melanoma	0.000236	0.00182	CcSEcCtD
Acamprosate—Anorexia—Carmustine—melanoma	0.000234	0.00181	CcSEcCtD
Acamprosate—Epistaxis—Docetaxel—melanoma	0.000234	0.0018	CcSEcCtD
Acamprosate—Thrombocytopenia—Temozolomide—melanoma	0.000233	0.00179	CcSEcCtD
Acamprosate—Feeling abnormal—Bleomycin—melanoma	0.000232	0.00179	CcSEcCtD
Acamprosate—Skin disorder—Temozolomide—melanoma	0.000231	0.00178	CcSEcCtD
Acamprosate—Hypotension—Carmustine—melanoma	0.00023	0.00177	CcSEcCtD
Acamprosate—Hyperhidrosis—Temozolomide—melanoma	0.00023	0.00177	CcSEcCtD
Acamprosate—Decreased appetite—Dactinomycin—melanoma	0.000228	0.00176	CcSEcCtD
Acamprosate—Anorexia—Temozolomide—melanoma	0.000226	0.00174	CcSEcCtD
Acamprosate—Pain—Dactinomycin—melanoma	0.000225	0.00173	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Carmustine—melanoma	0.000224	0.00173	CcSEcCtD
Acamprosate—Urticaria—Bleomycin—melanoma	0.000224	0.00172	CcSEcCtD
Acamprosate—Haemoglobin—Docetaxel—melanoma	0.000223	0.00172	CcSEcCtD
Acamprosate—Rhinitis—Docetaxel—melanoma	0.000223	0.00172	CcSEcCtD
Acamprosate—Body temperature increased—Bleomycin—melanoma	0.000223	0.00172	CcSEcCtD
Acamprosate—Haemorrhage—Docetaxel—melanoma	0.000222	0.00171	CcSEcCtD
Acamprosate—Hepatitis—Docetaxel—melanoma	0.000222	0.00171	CcSEcCtD
Acamprosate—Insomnia—Carmustine—melanoma	0.000222	0.00171	CcSEcCtD
Acamprosate—Hypoaesthesia—Docetaxel—melanoma	0.000221	0.0017	CcSEcCtD
Acamprosate—Paraesthesia—Carmustine—melanoma	0.000221	0.0017	CcSEcCtD
Acamprosate—Pharyngitis—Docetaxel—melanoma	0.000221	0.0017	CcSEcCtD
Acamprosate—Dyspnoea—Carmustine—melanoma	0.000219	0.00169	CcSEcCtD
Acamprosate—Oedema peripheral—Docetaxel—melanoma	0.000219	0.00169	CcSEcCtD
Acamprosate—Somnolence—Carmustine—melanoma	0.000219	0.00168	CcSEcCtD
Acamprosate—Feeling abnormal—Dactinomycin—melanoma	0.000216	0.00167	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Temozolomide—melanoma	0.000216	0.00167	CcSEcCtD
Acamprosate—Insomnia—Temozolomide—melanoma	0.000215	0.00166	CcSEcCtD
Acamprosate—Gastrointestinal pain—Dactinomycin—melanoma	0.000215	0.00165	CcSEcCtD
Acamprosate—Visual impairment—Docetaxel—melanoma	0.000214	0.00165	CcSEcCtD
Acamprosate—Decreased appetite—Carmustine—melanoma	0.000214	0.00165	CcSEcCtD
Acamprosate—Paraesthesia—Temozolomide—melanoma	0.000213	0.00164	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Carmustine—melanoma	0.000212	0.00163	CcSEcCtD
Acamprosate—Dyspnoea—Temozolomide—melanoma	0.000212	0.00163	CcSEcCtD
Acamprosate—Somnolence—Temozolomide—melanoma	0.000211	0.00163	CcSEcCtD
Acamprosate—Pain—Carmustine—melanoma	0.00021	0.00162	CcSEcCtD
Acamprosate—Constipation—Carmustine—melanoma	0.00021	0.00162	CcSEcCtD
Acamprosate—Dyspepsia—Temozolomide—melanoma	0.000209	0.00161	CcSEcCtD
Acamprosate—Body temperature increased—Dactinomycin—melanoma	0.000208	0.0016	CcSEcCtD
Acamprosate—Abdominal pain—Dactinomycin—melanoma	0.000208	0.0016	CcSEcCtD
Acamprosate—Hypersensitivity—Bleomycin—melanoma	0.000207	0.0016	CcSEcCtD
Acamprosate—Decreased appetite—Temozolomide—melanoma	0.000206	0.00159	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Temozolomide—melanoma	0.000205	0.00158	CcSEcCtD
Acamprosate—Pain—Temozolomide—melanoma	0.000203	0.00157	CcSEcCtD
Acamprosate—Constipation—Temozolomide—melanoma	0.000203	0.00157	CcSEcCtD
Acamprosate—Feeling abnormal—Carmustine—melanoma	0.000203	0.00156	CcSEcCtD
Acamprosate—Asthenia—Bleomycin—melanoma	0.000202	0.00156	CcSEcCtD
Acamprosate—Gastrointestinal pain—Carmustine—melanoma	0.000201	0.00155	CcSEcCtD
Acamprosate—Immune system disorder—Docetaxel—melanoma	0.000201	0.00155	CcSEcCtD
Acamprosate—Chills—Docetaxel—melanoma	0.0002	0.00154	CcSEcCtD
Acamprosate—Pruritus—Bleomycin—melanoma	0.000199	0.00153	CcSEcCtD
Acamprosate—Alopecia—Docetaxel—melanoma	0.000196	0.00151	CcSEcCtD
Acamprosate—Feeling abnormal—Temozolomide—melanoma	0.000196	0.00151	CcSEcCtD
Acamprosate—Mental disorder—Docetaxel—melanoma	0.000195	0.0015	CcSEcCtD
Acamprosate—Body temperature increased—Carmustine—melanoma	0.000194	0.0015	CcSEcCtD
Acamprosate—Abdominal pain—Carmustine—melanoma	0.000194	0.0015	CcSEcCtD
Acamprosate—Gastrointestinal pain—Temozolomide—melanoma	0.000194	0.0015	CcSEcCtD
Acamprosate—Malnutrition—Docetaxel—melanoma	0.000194	0.00149	CcSEcCtD
Acamprosate—Hypersensitivity—Dactinomycin—melanoma	0.000193	0.00149	CcSEcCtD
Acamprosate—Dysgeusia—Docetaxel—melanoma	0.00019	0.00146	CcSEcCtD
Acamprosate—Urticaria—Temozolomide—melanoma	0.000189	0.00145	CcSEcCtD
Acamprosate—Asthenia—Dactinomycin—melanoma	0.000188	0.00145	CcSEcCtD
Acamprosate—Body temperature increased—Temozolomide—melanoma	0.000188	0.00145	CcSEcCtD
Acamprosate—Abdominal pain—Temozolomide—melanoma	0.000188	0.00145	CcSEcCtD
Acamprosate—Back pain—Docetaxel—melanoma	0.000187	0.00144	CcSEcCtD
Acamprosate—Muscle spasms—Docetaxel—melanoma	0.000186	0.00143	CcSEcCtD
Acamprosate—Hypersensitivity—Carmustine—melanoma	0.000181	0.0014	CcSEcCtD
Acamprosate—Diarrhoea—Dactinomycin—melanoma	0.00018	0.00138	CcSEcCtD
Acamprosate—Vomiting—Bleomycin—melanoma	0.000179	0.00138	CcSEcCtD
Acamprosate—Anaemia—Docetaxel—melanoma	0.000179	0.00138	CcSEcCtD
Acamprosate—Rash—Bleomycin—melanoma	0.000178	0.00137	CcSEcCtD
Acamprosate—Dermatitis—Bleomycin—melanoma	0.000177	0.00137	CcSEcCtD
Acamprosate—Asthenia—Carmustine—melanoma	0.000176	0.00136	CcSEcCtD
Acamprosate—Hypersensitivity—Temozolomide—melanoma	0.000175	0.00135	CcSEcCtD
Acamprosate—Syncope—Docetaxel—melanoma	0.000174	0.00134	CcSEcCtD
Acamprosate—Leukopenia—Docetaxel—melanoma	0.000173	0.00133	CcSEcCtD
Acamprosate—Palpitations—Docetaxel—melanoma	0.000171	0.00132	CcSEcCtD
Acamprosate—Asthenia—Temozolomide—melanoma	0.00017	0.00131	CcSEcCtD
Acamprosate—Loss of consciousness—Docetaxel—melanoma	0.00017	0.00131	CcSEcCtD
Acamprosate—Cough—Docetaxel—melanoma	0.000169	0.0013	CcSEcCtD
Acamprosate—Diarrhoea—Carmustine—melanoma	0.000168	0.0013	CcSEcCtD
Acamprosate—Pruritus—Temozolomide—melanoma	0.000168	0.00129	CcSEcCtD
Acamprosate—Convulsion—Docetaxel—melanoma	0.000168	0.00129	CcSEcCtD
Acamprosate—Nausea—Bleomycin—melanoma	0.000167	0.00129	CcSEcCtD
Acamprosate—Hypertension—Docetaxel—melanoma	0.000167	0.00129	CcSEcCtD
Acamprosate—Vomiting—Dactinomycin—melanoma	0.000167	0.00129	CcSEcCtD
Acamprosate—Rash—Dactinomycin—melanoma	0.000166	0.00128	CcSEcCtD
Acamprosate—Arthralgia—Docetaxel—melanoma	0.000165	0.00127	CcSEcCtD
Acamprosate—Chest pain—Docetaxel—melanoma	0.000165	0.00127	CcSEcCtD
Acamprosate—Myalgia—Docetaxel—melanoma	0.000165	0.00127	CcSEcCtD
Acamprosate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000164	0.00126	CcSEcCtD
Acamprosate—Dizziness—Carmustine—melanoma	0.000163	0.00125	CcSEcCtD
Acamprosate—Diarrhoea—Temozolomide—melanoma	0.000163	0.00125	CcSEcCtD
Acamprosate—Dry mouth—Docetaxel—melanoma	0.000161	0.00124	CcSEcCtD
Acamprosate—Confusional state—Docetaxel—melanoma	0.000159	0.00123	CcSEcCtD
Acamprosate—Anaphylactic shock—Docetaxel—melanoma	0.000158	0.00122	CcSEcCtD
Acamprosate—Dizziness—Temozolomide—melanoma	0.000157	0.00121	CcSEcCtD
Acamprosate—Infection—Docetaxel—melanoma	0.000157	0.00121	CcSEcCtD
Acamprosate—Vomiting—Carmustine—melanoma	0.000156	0.0012	CcSEcCtD
Acamprosate—Nausea—Dactinomycin—melanoma	0.000156	0.0012	CcSEcCtD
Acamprosate—Shock—Docetaxel—melanoma	0.000155	0.0012	CcSEcCtD
Acamprosate—Rash—Carmustine—melanoma	0.000155	0.00119	CcSEcCtD
Acamprosate—Dermatitis—Carmustine—melanoma	0.000155	0.00119	CcSEcCtD
Acamprosate—Thrombocytopenia—Docetaxel—melanoma	0.000155	0.00119	CcSEcCtD
Acamprosate—Tachycardia—Docetaxel—melanoma	0.000154	0.00119	CcSEcCtD
Acamprosate—Headache—Carmustine—melanoma	0.000154	0.00119	CcSEcCtD
Acamprosate—Skin disorder—Docetaxel—melanoma	0.000153	0.00118	CcSEcCtD
Acamprosate—Vomiting—Temozolomide—melanoma	0.000151	0.00116	CcSEcCtD
Acamprosate—Anorexia—Docetaxel—melanoma	0.000151	0.00116	CcSEcCtD
Acamprosate—Rash—Temozolomide—melanoma	0.00015	0.00115	CcSEcCtD
Acamprosate—Dermatitis—Temozolomide—melanoma	0.00015	0.00115	CcSEcCtD
Acamprosate—Headache—Temozolomide—melanoma	0.000149	0.00115	CcSEcCtD
Acamprosate—Hypotension—Docetaxel—melanoma	0.000148	0.00114	CcSEcCtD
Acamprosate—Nausea—Carmustine—melanoma	0.000146	0.00112	CcSEcCtD
Acamprosate—Musculoskeletal discomfort—Docetaxel—melanoma	0.000144	0.00111	CcSEcCtD
Acamprosate—Insomnia—Docetaxel—melanoma	0.000143	0.0011	CcSEcCtD
Acamprosate—Paraesthesia—Docetaxel—melanoma	0.000142	0.00109	CcSEcCtD
Acamprosate—Nausea—Temozolomide—melanoma	0.000141	0.00109	CcSEcCtD
Acamprosate—Dyspnoea—Docetaxel—melanoma	0.000141	0.00109	CcSEcCtD
Acamprosate—Somnolence—Docetaxel—melanoma	0.00014	0.00108	CcSEcCtD
Acamprosate—Dyspepsia—Docetaxel—melanoma	0.000139	0.00107	CcSEcCtD
Acamprosate—Decreased appetite—Docetaxel—melanoma	0.000137	0.00106	CcSEcCtD
Acamprosate—Gastrointestinal disorder—Docetaxel—melanoma	0.000136	0.00105	CcSEcCtD
Acamprosate—Pain—Docetaxel—melanoma	0.000135	0.00104	CcSEcCtD
Acamprosate—Constipation—Docetaxel—melanoma	0.000135	0.00104	CcSEcCtD
Acamprosate—Feeling abnormal—Docetaxel—melanoma	0.00013	0.001	CcSEcCtD
Acamprosate—Gastrointestinal pain—Docetaxel—melanoma	0.000129	0.000995	CcSEcCtD
Acamprosate—Abdominal pain—Docetaxel—melanoma	0.000125	0.000962	CcSEcCtD
Acamprosate—Body temperature increased—Docetaxel—melanoma	0.000125	0.000962	CcSEcCtD
Acamprosate—Hypersensitivity—Docetaxel—melanoma	0.000116	0.000897	CcSEcCtD
Acamprosate—Asthenia—Docetaxel—melanoma	0.000113	0.000873	CcSEcCtD
Acamprosate—Pruritus—Docetaxel—melanoma	0.000112	0.000861	CcSEcCtD
Acamprosate—Diarrhoea—Docetaxel—melanoma	0.000108	0.000833	CcSEcCtD
Acamprosate—Dizziness—Docetaxel—melanoma	0.000104	0.000805	CcSEcCtD
Acamprosate—Vomiting—Docetaxel—melanoma	0.0001	0.000774	CcSEcCtD
Acamprosate—Rash—Docetaxel—melanoma	9.96e-05	0.000767	CcSEcCtD
Acamprosate—Dermatitis—Docetaxel—melanoma	9.95e-05	0.000767	CcSEcCtD
Acamprosate—Headache—Docetaxel—melanoma	9.9e-05	0.000762	CcSEcCtD
Acamprosate—Nausea—Docetaxel—melanoma	9.38e-05	0.000723	CcSEcCtD
Acamprosate—GRM5—Signaling Pathways—FOXO4—melanoma	4.45e-05	0.000271	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HDAC2—melanoma	4.45e-05	0.000271	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCR4—melanoma	4.45e-05	0.000271	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—GNAQ—melanoma	4.4e-05	0.000268	CbGpPWpGaD
Acamprosate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	4.36e-05	0.000265	CbGpPWpGaD
Acamprosate—GRIN2C—Transmission across Chemical Synapses—HRAS—melanoma	4.29e-05	0.000261	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—PRKCA—melanoma	4.27e-05	0.00026	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CG—melanoma	4.24e-05	0.000258	CbGpPWpGaD
Acamprosate—SLC36A1—Transmembrane transport of small molecules—ALB—melanoma	4.2e-05	0.000256	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—PRKCA—melanoma	4.19e-05	0.000255	CbGpPWpGaD
Acamprosate—GRIN1—Spinal Cord Injury—IL6—melanoma	4.17e-05	0.000254	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SYK—melanoma	4.14e-05	0.000252	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—TNF—melanoma	4.13e-05	0.000252	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CD—melanoma	4.1e-05	0.00025	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—BRAF—melanoma	4.1e-05	0.00025	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—MAPK1—melanoma	4.09e-05	0.000249	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—ITGB3—melanoma	4.09e-05	0.000249	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—MAPK1—melanoma	4.08e-05	0.000248	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ITGAV—melanoma	4.06e-05	0.000247	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NGFR—melanoma	4.06e-05	0.000247	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT3—melanoma	4.06e-05	0.000247	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—BRAF—melanoma	4.02e-05	0.000245	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MAP2K2—melanoma	4e-05	0.000244	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—CASP3—melanoma	4e-05	0.000243	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—ITGB3—melanoma	3.99e-05	0.000243	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—MDM2—melanoma	3.99e-05	0.000243	CbGpPWpGaD
Acamprosate—GRIN2D—Transmission across Chemical Synapses—HRAS—melanoma	3.99e-05	0.000243	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP2—melanoma	3.98e-05	0.000243	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MAP2K1—melanoma	3.98e-05	0.000242	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—melanoma	3.92e-05	0.000239	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MAP2K2—melanoma	3.9e-05	0.000238	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—MDM2—melanoma	3.89e-05	0.000237	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP2—melanoma	3.88e-05	0.000236	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MAP2K1—melanoma	3.88e-05	0.000236	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—CTNNB1—melanoma	3.85e-05	0.000235	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—MAPK1—melanoma	3.81e-05	0.000232	CbGpPWpGaD
Acamprosate—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	3.8e-05	0.000231	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—RAC1—melanoma	3.8e-05	0.000231	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SOCS1—melanoma	3.76e-05	0.000229	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—MAP2K1—melanoma	3.75e-05	0.000228	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—S100B—melanoma	3.75e-05	0.000228	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—NFKB1—melanoma	3.74e-05	0.000228	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CD—melanoma	3.73e-05	0.000227	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—HRAS—melanoma	3.72e-05	0.000226	CbGpPWpGaD
Acamprosate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	3.7e-05	0.000226	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—RAC1—melanoma	3.7e-05	0.000225	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—PRKCA—melanoma	3.66e-05	0.000223	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—HRAS—melanoma	3.62e-05	0.000221	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ERBB4—melanoma	3.59e-05	0.000218	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CB—melanoma	3.58e-05	0.000218	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—MAPK1—melanoma	3.56e-05	0.000217	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CDKN2B—melanoma	3.55e-05	0.000217	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—BRAF—melanoma	3.52e-05	0.000214	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—ERBB2—melanoma	3.49e-05	0.000213	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KDR—melanoma	3.48e-05	0.000212	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—MAPK1—melanoma	3.47e-05	0.000211	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CD86—melanoma	3.44e-05	0.000209	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—CXCL8—melanoma	3.44e-05	0.000209	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—MDM2—melanoma	3.43e-05	0.000209	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EDN1—melanoma	3.41e-05	0.000208	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MET—melanoma	3.41e-05	0.000207	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CDK4—melanoma	3.41e-05	0.000207	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—ERBB2—melanoma	3.4e-05	0.000207	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—KDR—melanoma	3.39e-05	0.000207	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—MDM2—melanoma	3.37e-05	0.000205	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CXCL8—melanoma	3.36e-05	0.000205	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—STAT3—melanoma	3.36e-05	0.000205	CbGpPWpGaD
Acamprosate—GRIN1—SIDS Susceptibility Pathways—IL6—melanoma	3.34e-05	0.000203	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CSF2—melanoma	3.33e-05	0.000203	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FGF1—melanoma	3.33e-05	0.000203	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MET—melanoma	3.32e-05	0.000202	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CDK4—melanoma	3.32e-05	0.000202	CbGpPWpGaD
Acamprosate—GRIN2C—Neuronal System—HRAS—melanoma	3.29e-05	0.0002	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—IL2—melanoma	3.28e-05	0.0002	CbGpPWpGaD
Acamprosate—GRIN1—BDNF signaling pathway—AKT1—melanoma	3.28e-05	0.0002	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NOTCH1—melanoma	3.28e-05	0.0002	CbGpPWpGaD
Acamprosate—GRIN2A—Transmission across Chemical Synapses—HRAS—melanoma	3.27e-05	0.000199	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—SLC5A5—melanoma	3.27e-05	0.000199	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—E2F1—melanoma	3.26e-05	0.000199	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CB—melanoma	3.25e-05	0.000198	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PDGFRA—melanoma	3.23e-05	0.000197	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CASP3—melanoma	3.22e-05	0.000196	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—SLC5A5—melanoma	3.21e-05	0.000195	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK3—melanoma	3.21e-05	0.000195	CbGpPWpGaD
Acamprosate—GRIN2B—BDNF signaling pathway—AKT1—melanoma	3.2e-05	0.000195	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NOTCH1—melanoma	3.2e-05	0.000195	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PRKCA—melanoma	3.2e-05	0.000195	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ITGB3—melanoma	3.2e-05	0.000195	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—BRAF—melanoma	3.14e-05	0.000191	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—SPP1—melanoma	3.13e-05	0.000191	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—MAPK1—melanoma	3.13e-05	0.00019	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAP2K2—melanoma	3.12e-05	0.00019	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	3.12e-05	0.00019	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—CXCL8—melanoma	3.12e-05	0.00019	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—CTNNB1—melanoma	3.1e-05	0.000189	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—PPARG—melanoma	3.09e-05	0.000188	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—BRAF—melanoma	3.08e-05	0.000188	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	3.07e-05	0.000187	CbGpPWpGaD
Acamprosate—GRIN2D—Neuronal System—HRAS—melanoma	3.06e-05	0.000186	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—MAPK1—melanoma	3.05e-05	0.000186	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—PPARG—melanoma	3.02e-05	0.000184	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—NFKB1—melanoma	3.01e-05	0.000183	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MMP9—melanoma	2.99e-05	0.000182	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL2—melanoma	2.98e-05	0.000182	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TERT—melanoma	2.97e-05	0.000181	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—RAC1—melanoma	2.96e-05	0.00018	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—MDM2—melanoma	2.95e-05	0.00018	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MMP9—melanoma	2.92e-05	0.000178	CbGpPWpGaD
Acamprosate—GRIN1—Transmission across Chemical Synapses—HRAS—melanoma	2.86e-05	0.000174	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HIF1A—melanoma	2.84e-05	0.000173	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP2—melanoma	2.84e-05	0.000173	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MAP2K1—melanoma	2.84e-05	0.000173	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—SLC5A5—melanoma	2.81e-05	0.000171	CbGpPWpGaD
Acamprosate—GRIN2B—Transmission across Chemical Synapses—HRAS—melanoma	2.78e-05	0.00017	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP2—melanoma	2.77e-05	0.000169	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MAP2K1—melanoma	2.77e-05	0.000168	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—VEGFA—melanoma	2.73e-05	0.000166	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—MAPK1—melanoma	2.73e-05	0.000166	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KDR—melanoma	2.72e-05	0.000166	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—FGF2—melanoma	2.7e-05	0.000164	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—BRAF—melanoma	2.7e-05	0.000164	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—VEGFA—melanoma	2.69e-05	0.000164	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—melanoma	2.68e-05	0.000163	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—MAPK1—melanoma	2.66e-05	0.000162	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—NRAS—melanoma	2.65e-05	0.000162	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—MDM2—melanoma	2.63e-05	0.00016	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—FGF2—melanoma	2.63e-05	0.00016	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—VEGFA—melanoma	2.62e-05	0.00016	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FN1—melanoma	2.62e-05	0.000159	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—NRAS—melanoma	2.59e-05	0.000158	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—MDM2—melanoma	2.58e-05	0.000157	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NOTCH1—melanoma	2.56e-05	0.000156	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MAPK3—melanoma	2.54e-05	0.000155	CbGpPWpGaD
Acamprosate—GRIN2A—Neuronal System—HRAS—melanoma	2.51e-05	0.000153	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CD80—melanoma	2.51e-05	0.000153	CbGpPWpGaD
Acamprosate—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	2.51e-05	0.000153	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CG—melanoma	2.5e-05	0.000152	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KIT—melanoma	2.5e-05	0.000152	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—APC—melanoma	2.5e-05	0.000152	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—NRAS—melanoma	2.5e-05	0.000152	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ABCB1—melanoma	2.49e-05	0.000152	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—ERBB2—melanoma	2.49e-05	0.000152	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MAPK3—melanoma	2.48e-05	0.000151	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EGF—melanoma	2.47e-05	0.000151	CbGpPWpGaD
Acamprosate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	2.46e-05	0.00015	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—HRAS—melanoma	2.45e-05	0.000149	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ABCB1—melanoma	2.45e-05	0.000149	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—ERBB2—melanoma	2.43e-05	0.000148	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—MAPK1—melanoma	2.42e-05	0.000147	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—EGFR—melanoma	2.42e-05	0.000147	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—MAPK3—melanoma	2.4e-05	0.000146	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—MAPK1—melanoma	2.36e-05	0.000144	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—EGFR—melanoma	2.36e-05	0.000144	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—BRAF—melanoma	2.35e-05	0.000143	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—MAPK1—melanoma	2.35e-05	0.000143	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—TNF—melanoma	2.34e-05	0.000143	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—MAPK1—melanoma	2.31e-05	0.00014	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IGF1—melanoma	2.29e-05	0.00014	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—KRAS—melanoma	2.28e-05	0.000139	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—MAPK1—melanoma	2.28e-05	0.000139	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—EGFR—melanoma	2.28e-05	0.000139	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—MDM2—melanoma	2.26e-05	0.000138	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—KRAS—melanoma	2.23e-05	0.000136	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAP2K1—melanoma	2.22e-05	0.000135	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CD—melanoma	2.2e-05	0.000134	CbGpPWpGaD
Acamprosate—GRIN1—Neuronal System—HRAS—melanoma	2.19e-05	0.000133	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—PIK3CA—melanoma	2.18e-05	0.000133	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—CTNNB1—melanoma	2.18e-05	0.000133	CbGpPWpGaD
Acamprosate—GABRB3—BDNF signaling pathway—AKT1—melanoma	2.16e-05	0.000132	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—KRAS—melanoma	2.15e-05	0.000131	CbGpPWpGaD
Acamprosate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—melanoma	2.15e-05	0.000131	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ABCB1—melanoma	2.14e-05	0.00013	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MMP9—melanoma	2.14e-05	0.00013	CbGpPWpGaD
Acamprosate—GRIN2B—Neuronal System—HRAS—melanoma	2.13e-05	0.00013	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—CTNNB1—melanoma	2.12e-05	0.000129	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NFKB1—melanoma	2.11e-05	0.000129	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—FGF2—melanoma	2.11e-05	0.000128	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MMP9—melanoma	2.08e-05	0.000127	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NFKB1—melanoma	2.06e-05	0.000125	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—MAPK1—melanoma	2.01e-05	0.000123	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—PIK3CA—melanoma	1.98e-05	0.000121	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MDM2—melanoma	1.97e-05	0.00012	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—ERBB2—melanoma	1.94e-05	0.000118	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—HRAS—melanoma	1.94e-05	0.000118	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CB—melanoma	1.92e-05	0.000117	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—VEGFA—melanoma	1.92e-05	0.000117	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—STAT3—melanoma	1.9e-05	0.000116	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—NRAS—melanoma	1.89e-05	0.000115	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—HRAS—melanoma	1.89e-05	0.000115	CbGpPWpGaD
Acamprosate—GABRA1—SIDS Susceptibility Pathways—IL6—melanoma	1.89e-05	0.000115	CbGpPWpGaD
Acamprosate—GABRB3—Transmission across Chemical Synapses—HRAS—melanoma	1.88e-05	0.000115	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—VEGFA—melanoma	1.87e-05	0.000114	CbGpPWpGaD
Acamprosate—GRIN1—Axon guidance—IL6—melanoma	1.86e-05	0.000113	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—STAT3—melanoma	1.85e-05	0.000113	CbGpPWpGaD
Acamprosate—GABRG2—Transmission across Chemical Synapses—HRAS—melanoma	1.85e-05	0.000113	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—NRAS—melanoma	1.85e-05	0.000112	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CXCL8—melanoma	1.84e-05	0.000112	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—HRAS—melanoma	1.83e-05	0.000112	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MAPK3—melanoma	1.81e-05	0.00011	CbGpPWpGaD
Acamprosate—GRIN2B—Axon guidance—IL6—melanoma	1.81e-05	0.00011	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CDKN1B—melanoma	1.8e-05	0.00011	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—MAPK1—melanoma	1.8e-05	0.00011	CbGpPWpGaD
Acamprosate—GRM5—GPCR downstream signaling—AKT1—melanoma	1.78e-05	0.000108	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MAPK3—melanoma	1.77e-05	0.000108	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—MAPK1—melanoma	1.77e-05	0.000108	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CASP3—melanoma	1.76e-05	0.000107	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL2—melanoma	1.76e-05	0.000107	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—IL6—melanoma	1.75e-05	0.000107	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—MAPK1—melanoma	1.73e-05	0.000105	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—EGFR—melanoma	1.73e-05	0.000105	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CCND1—melanoma	1.72e-05	0.000105	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CTNNB1—melanoma	1.7e-05	0.000104	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—MAPK1—melanoma	1.68e-05	0.000102	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—EGFR—melanoma	1.68e-05	0.000102	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MMP9—melanoma	1.67e-05	0.000102	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—CDKN1A—melanoma	1.66e-05	0.000101	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PTEN—melanoma	1.66e-05	0.000101	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NFKB1—melanoma	1.65e-05	0.0001	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—TNF—melanoma	1.64e-05	0.0001	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—KRAS—melanoma	1.63e-05	9.93e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmission across Chemical Synapses—HRAS—melanoma	1.62e-05	9.85e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling by GPCR—AKT1—melanoma	1.62e-05	9.85e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—TNF—melanoma	1.6e-05	9.76e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—KRAS—melanoma	1.59e-05	9.68e-05	CbGpPWpGaD
Acamprosate—GABRB3—Transmembrane transport of small molecules—ALB—melanoma	1.56e-05	9.5e-05	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—MAPK1—melanoma	1.54e-05	9.4e-05	CbGpPWpGaD
Acamprosate—GABRG2—Transmembrane transport of small molecules—ALB—melanoma	1.53e-05	9.32e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—VEGFA—melanoma	1.5e-05	9.12e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—STAT3—melanoma	1.48e-05	9.03e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—NRAS—melanoma	1.48e-05	9.01e-05	CbGpPWpGaD
Acamprosate—GABRB3—Neuronal System—HRAS—melanoma	1.44e-05	8.79e-05	CbGpPWpGaD
Acamprosate—GABRG2—Neuronal System—HRAS—melanoma	1.42e-05	8.64e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK3—melanoma	1.42e-05	8.63e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—HRAS—melanoma	1.39e-05	8.44e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MYC—melanoma	1.38e-05	8.39e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—HRAS—melanoma	1.35e-05	8.23e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—MAPK1—melanoma	1.35e-05	8.21e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—EGFR—melanoma	1.35e-05	8.21e-05	CbGpPWpGaD
Acamprosate—GABRA1—Transmembrane transport of small molecules—ALB—melanoma	1.34e-05	8.15e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—IL6—melanoma	1.33e-05	8.08e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—IL6—melanoma	1.29e-05	7.88e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—KRAS—melanoma	1.27e-05	7.75e-05	CbGpPWpGaD
Acamprosate—GABRA1—Neuronal System—HRAS—melanoma	1.24e-05	7.55e-05	CbGpPWpGaD
Acamprosate—GRIN1—Developmental Biology—AKT1—melanoma	1.22e-05	7.45e-05	CbGpPWpGaD
Acamprosate—GRIN2B—Developmental Biology—AKT1—melanoma	1.19e-05	7.27e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—PIK3CA—melanoma	1.17e-05	7.12e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—TP53—melanoma	1.13e-05	6.89e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—HRAS—melanoma	1.08e-05	6.59e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—IL6—melanoma	1.04e-05	6.31e-05	CbGpPWpGaD
Acamprosate—GRM5—Signaling Pathways—AKT1—melanoma	9.55e-06	5.82e-05	CbGpPWpGaD
